Opinion|Videos|December 25, 2024

Exploring Second-Line Treatments for PBC

Panelists discuss how some patients with primary biliary cholangitis (PBC) have an inadequate response to ursodeoxycholic acid and require second-line treatments, with options including obeticholic acid, seladelpar, and elafibranor, which improve bile acid homeostasis and reduce inflammation.

Video content above is prompted by the following:

  1. How often do patients require second-line treatments for PBC, and what agents are available for second-line management?
  2. How do the mechanisms of action differ between seladelpar, elafibranor, and obeticholic acid?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME